Funding for this research was provided by:
National Cancer Institute (F30 CA180607, P30 CA006927, R21 CA223394-01A1, R01 CA218802-01A1)
Received: 3 September 2018
Accepted: 3 April 2019
First Online: 24 April 2019
Ethics approval and consent to participate
: Not applicable.
: The patient provided written informed consent to publish this report and associated images.
: Y.B. has served on advisory boards of Astra Zeneca, Abbvie, and Caris Life Sciences. The authors have no other conflicts to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.